Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu).
about
Ebola virus diseaseThe Role of Cytokines and Chemokines in Filovirus InfectionEbolavirus comparative genomicsEbola: a holistic approach is required to achieve effective management and controlIdentification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virusImmune memory to Sudan virus: comparison between two separate disease outbreaks.Treatment of Ebola virus infection with antibodies from reconvalescent donors.The Ebola epidemic crystallizes the potential of passive antibody therapy for infectious diseases.The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses.Correspondence of Neutralizing Humoral Immunity and CD4 T Cell Responses in Long Recovered Sudan Virus SurvivorsHuman Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody Responses.Characterization of host immune responses in Ebola virus infections.Sudan ebolavirus long recovered survivors produce GP-specific Abs that are of the IgG1 subclass and preferentially bind FcγRIMarburg virus survivor immune responses are Th1 skewed with limited neutralizing antibody responses.Host Factors Involved in Ebola Virus Replication.Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies.Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease.Curbing Ebola infections among healthcare workers in West Africa: unconventional strategies needed.Ebola Virus Neutralizing Antibodies Detectable in Survivors of theYambuku, Zaire Outbreak 40 Years after Infection.Seroprevalence of Ebola virus infection in Bombali District, Sierra Leone.Immune barriers of Ebola virus infection.The structural basis for filovirus neutralization by monoclonal antibodies
P2860
Q24563097-F09AE6EE-5EA9-4E68-B784-B6D7527C5BCAQ26778003-C25DD59F-C9D4-4C8C-8F06-D55E3DDC3DC3Q26801790-4179E29B-A086-4215-9816-3B86FC6490F5Q26823792-995AA320-098A-4342-B2CD-DC60970325EBQ33733844-2CA24BA8-A4EF-4286-9882-4715FF792578Q35014908-B8DDC3D7-FEC0-4D6E-AA80-60B111115AE1Q35130375-C0D25886-8305-46C2-9954-C56392EB6816Q35532972-10C60DB5-FC5D-4602-A746-4C358EB1C2FAQ36216308-0E26980D-0FF0-4AB8-9BA1-DF087632C79AQ36947021-D54E2CA1-5D4E-4D41-BF97-1DCB3C455946Q37163676-CCAEF8FD-40C9-40E1-8698-6FA2828B7BCAQ38205274-2B87CF58-841B-4048-8232-294D43006183Q38848145-33EFFB29-BD42-4813-81EF-E31AA9A5A724Q38848150-CD277F3A-B116-4C4C-9CFB-2EF6C3912D95Q39436358-D864FA0A-2B0B-4526-B603-8A80BA3FCBDCQ40122905-6DC33165-69E7-4A97-9C88-375BEF9568F9Q40155280-B45F327C-4A09-4965-9AB7-32FE3493488DQ42601807-1FAEF891-9974-42EE-91C7-B7B52D5AC748Q46653237-7D529426-FAF2-4EA4-9F43-3BFC5AC2A819Q49874119-EEEA86EE-8A2C-4843-B9C4-073190FA358BQ49917351-656C78B8-0218-4429-B2F1-4CF07D382B9DQ56536340-A6EAF22C-5FFE-497E-B5B5-2C56E1F9ABC8
P2860
Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Profile and persistence of the ...... rs of Sudan ebolavirus (Gulu).
@en
type
label
Profile and persistence of the ...... rs of Sudan ebolavirus (Gulu).
@en
prefLabel
Profile and persistence of the ...... rs of Sudan ebolavirus (Gulu).
@en
P2093
P2860
P356
P1476
Profile and persistence of the ...... rs of Sudan ebolavirus (Gulu).
@en
P2093
Allison Groseth
Ana I Kuehne
Eddie Perelman
John M Dye
Julius Julian Lutwama
Leslie Lobel
Majidat Muhammad
Olga Dolnik
Robert S Marks
Stephan Becker
P2860
P304
P356
10.1093/INFDIS/JIT162
P407
P577
2013-04-12T00:00:00Z